Skip to main content

Peer Review reports

From: Efficacy and safety of intravitreal aflibercept in ranibizumab-refractory patients with neovascular age-related macular degeneration

Original Submission
7 Oct 2020 Submitted Original manuscript
13 Nov 2020 Author responded Author comments - Sam Razavi
Resubmission - Version 2
13 Nov 2020 Submitted Manuscript version 2
11 Jan 2021 Author responded Author comments - Sam Razavi
25 Nov 2020 Reviewed Reviewer Report
6 Dec 2020 Reviewed Reviewer Report
14 Dec 2020 Reviewed Reviewer Report
16 Dec 2020 Reviewed Reviewer Report
Resubmission - Version 3
11 Jan 2021 Submitted Manuscript version 3
13 Jan 2021 Reviewed Reviewer Report
30 Jan 2021 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
2 Feb 2021 Editorially accepted
17 Feb 2021 Article published 10.1186/s12886-021-01841-6

You can find further information about peer review here.

Back to article page
\